236 related articles for article (PubMed ID: 12351139)
1. Highlights of the eighth international conference on carcinogenic/mutagenic N-substituted aryl compounds.
Snyderwine EG; Sinha R; Felton JS; Ferguson LR
Mutat Res; 2002 Sep; 506-507():1-8. PubMed ID: 12351139
[TBL] [Abstract][Full Text] [Related]
2. Proceedings of the 8th International Conference on Carcinogenic/Mutagenic N-Substituted Aryl Compounds. Washington, DC, USA, 12-14 November 2001.
Mutat Res; 2002 Sep; 506-507():1-249. PubMed ID: 12452144
[No Abstract] [Full Text] [Related]
3. Comments on the history and importance of aromatic and heterocyclic amines in public health.
Weisburger JH
Mutat Res; 2002 Sep; 506-507():9-20. PubMed ID: 12351140
[TBL] [Abstract][Full Text] [Related]
4. Environmental and chemical carcinogenesis.
Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
[TBL] [Abstract][Full Text] [Related]
5. Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer.
Gan J; Skipper PL; Gago-Dominguez M; Arakawa K; Ross RK; Yu MC; Tannenbaum SR
J Natl Cancer Inst; 2004 Oct; 96(19):1425-31. PubMed ID: 15467031
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the presence of mutagenic arylamines in human breast milk and DNA adducts in exfoliated breast ductal epithelial cells.
Thompson PA; DeMarini DM; Kadlubar FF; McClure GY; Brooks LR; Green BL; Fares MY; Stone A; Josephy PD; Ambrosone CB
Environ Mol Mutagen; 2002; 39(2-3):134-42. PubMed ID: 11921181
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of oxidative DNA damage induced by carcinogenic arylamines.
Murata M; Kawanishi S
Front Biosci (Landmark Ed); 2011 Jan; 16(3):1132-43. PubMed ID: 21196222
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of cancer from exposure to arylamines.
Vineis P
Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):7-10. PubMed ID: 7889862
[TBL] [Abstract][Full Text] [Related]
9. Molecular dosimetry of aromatic amines in human populations.
Skipper PL; Tannenbaum SR
Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):17-21. PubMed ID: 7889842
[TBL] [Abstract][Full Text] [Related]
10. Sixth International Conference on Carcinogenic/Mutagenic N-Substituted Aryl Compounds. Monterey, California, November 4-8, 1995. Proceedings.
Mutat Res; 1997 May; 376(1-2):1-272. PubMed ID: 9202731
[No Abstract] [Full Text] [Related]
11. Arylamine-DNA adducts in vitro and in vivo: their role in bacterial mutagenesis and urinary bladder carcinogenesis.
Beland FA; Beranek DT; Dooley KL; Heflich RH; Kadlubar FF
Environ Health Perspect; 1983 Mar; 49():125-34. PubMed ID: 6339219
[TBL] [Abstract][Full Text] [Related]
12. Molecular epizootiology: assessment of exposure to genotoxic compounds in teleosts.
Stein JE; Reichert WL; Varanasi U
Environ Health Perspect; 1994 Dec; 102 Suppl 12(Suppl 12):19-23. PubMed ID: 7713027
[TBL] [Abstract][Full Text] [Related]
13. DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis.
Schut HA; Snyderwine EG
Carcinogenesis; 1999 Mar; 20(3):353-68. PubMed ID: 10190547
[TBL] [Abstract][Full Text] [Related]
14. Primary aromatic amines and cancer: Novel mechanistic insights using 4-aminobiphenyl as a model carcinogen.
Wang S; Hanna D; Sugamori KS; Grant DM
Pharmacol Ther; 2019 Aug; 200():179-189. PubMed ID: 31075357
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of fecal mutagenicity and colorectal cancer risk.
de Kok TM; van Maanen JM
Mutat Res; 2000 Jul; 463(1):53-101. PubMed ID: 10838209
[TBL] [Abstract][Full Text] [Related]
16. Organ specificity of the bladder carcinogen 4-aminobiphenyl in inducing DNA damage and mutation in mice.
Yoon JI; Kim SI; Tommasi S; Besaratinia A
Cancer Prev Res (Phila); 2012 Feb; 5(2):299-308. PubMed ID: 22086680
[TBL] [Abstract][Full Text] [Related]
17. Carcinogenicity of food mutagens.
Sugimura T; Nagao M; Wakabayashi K
Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):429-33. PubMed ID: 8781358
[TBL] [Abstract][Full Text] [Related]
18. Etheno-adduct-forming chemicals: from mutagenicity testing to tumor mutation spectra.
Barbin A
Mutat Res; 2000 Apr; 462(2-3):55-69. PubMed ID: 10767618
[TBL] [Abstract][Full Text] [Related]
19. Food mutagens.
Goldman R; Shields PG
J Nutr; 2003 Mar; 133 Suppl 3():965S-973S. PubMed ID: 12612183
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology in cancer risk assessment and prevention: recent progress and avenues for future research.
Wogan GN
Environ Health Perspect; 1992 Nov; 98():167-78. PubMed ID: 1486846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
